Abstract: The invention discloses the pharmaceutically acceptable salts of an optically active quinolone compound useful against infection, specifically the pharmaceutically acceptable salts of (S)-6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid. The pharmaceutically acceptable salts of the present invention are stable and have improved water solubility. They possess higher biological activity, less toxicity for kidney and no irritation to skin and muscle.

Abstract: A set of geldanamycin derivatives and their preparation methods. Pharmaceutical compositions comprising the said compounds as an active ingredient which are used as antivirus and antitumor agents. The said derivatives are used in the manufacture of heat shock protein 90 (Hsp 90) inhibiting agents which have the utility as antivirus and antitumor agents.

Abstract: Access to system and user defined entities (objects, data items, or the like) is managed by a content manager. A privilege grants a user an ability to access system such controlled entities. An item is an atomic user data entity stored in the CM library server. A privileges table is used to store system and user defined privileges. A privilege is represented by a row in the table. Each privilege has a unique privilege code, with codes 0 to 999 reserved to store system-defined privileges and codes beyond 999 open for user-defined privileges thus allowing application specific privileges to be added without limit.

Abstract: A method of controlling access in a content management system includes defining a domain among a plurality of domains for the content management system and designating a domain administrator for the domain. This enables the domain administrator to perform administrative tasks within the domain without revealing or affecting information in other domains of the content management system. For example, a domain administrator can view user information only for users associated with that domain. The domain administrator also can associate a user with only the defined domain, thereby limiting the user's access to information in the system to information associated with the domain.

Abstract: This invention relates generally to the field of glycated protein detection. In particular, the invention provides chimeric proteins, nucleic acids encoding the chimeric proteins, methods and kits for assaying for a glycated protein in a sample, using inter alia, an amadoriase.

Abstract: System and method for authorizing access to an entity by a user, by binding an access control list to each entity; specifying for the user a set of user privileges; intersecting the access control list and set of user privileges in a compiled ACL table; incrementally refreshing the compiled ACL table responsive to run time modification of relevant tables containing the access control list and set of user privileges; and referencing the compiled access control list to authorize a user request to access an entity.

Abstract: A system and method for authorizing access to a controlled entity by a user. A set of user privileges is provided for user; and a content manager intersects an access control list (ACL) and the set of user privileges to authorize access. Binding level control indicia selectively binds an access control list (ACL) to the controlled entity at item type, item, mixed, or library binding level. An item type comprises one or more component items with each component item having one or more item views which together form an item type view. A content manager is responsive to the binding level to perform ACL checking for authorizing access to the controlled entity by the user.

Abstract: This invention relates generally to the field of glycated protein detection. In particular, the invention provides chimeric proteins, nucleic acids encoding the chimeric proteins, methods and kits for assaying for a glycated protein in a sample, using inter alia, an amadoriase.

Abstract: Access to system and user defined entities (objects, data items, or the like) is managed by a content manager. A privilege grants a user an ability to access system such controlled entities. An item is an atomic user data entity stored in the CM library server. A privileges table is used to store system and user defined privileges. A privilege is represented by a row in the table. Each privilege has a unique privilege code, with codes 0 to 999 reserved to store system-defined privileges and codes beyond 999 open for user-defined privileges thus allowing application specific privileges to be added without limit.

Abstract: Access to system and user defined entities (objects, data items, or the like) is managed by a content manager. A privilege grants a user an ability to access system such controlled entities. An item is an atomic user data entity stored in the CM library server. A privileges table is used to store system and user defined privileges. A privilege is represented by a row in the table. Each privilege has a unique privilege code, with codes 0 to 999 reserved to store system-defined privileges and codes beyond 999 open for user-defined privileges thus allowing application specific privileges to be added without limit.

Abstract: This invention relates generally to the field of glycated protein detection. In particular, the invention provides chimeric proteins, nucleic acids encoding the chimeric proteins, methods and kits for assaying for a glycated protein in a sample, using inter alia, an amadoriase.

Abstract: A system and method of controlling access in a content management system includes defining a domain among a plurality of domains for the content management system and designating a domain administrator for the domain. This enables the domain administrator to perform administrative tasks within the domain without revealing or affecting information in other domains of the content management system. For example, a domain administrator can view user information only for users associated with that domain.

Abstract: System and method for authorizing access to an entity by a user, by binding an access control list to each entity; specifying for the user a set of user privileges; intersecting the access control list and set of user privileges in a compiled ACL table; incrementally refreshing the compiled ACL table responsive to run time modification of relevant tables containing the access control list and set of user privileges; and referencing the compiled access control list to authorize a user request to access an entity.

Abstract: Access to system and user defined entities (objects, data items, or the like) is managed by a content manager. A privilege grants a user an ability to access system such controlled entities. An item is an atomic user data entity stored in the CM library server. A privileges table is used to store system and user defined privileges. A privilege is represented by a row in the table. Each privilege has a unique privilege code, with codes 0 to 999 reserved to store system-defined privileges and codes beyond 999 open for user-defined privileges thus allowing application specific privileges to be added without limit.

Abstract: A system and method for authorizing access to a controlled entity by a user. A set of user privileges is provided for user; and a content manager intersects an access control list (ACL) and the set of user privileges to authorize access. Binding level control indicia selectively binds an access control list (ACL) to the controlled entity at item type, item, mixed, or library binding level. An item type comprises one or more component items with each component item having one or more item views which together form an item type view. A content manager is responsive to the binding level to perform ACL checking for authorizing access to the controlled entity by the user.